Status:
COMPLETED
Transatrial Pericardial Separation to Enhance Safety of Subxiphoid Pericardial Access for Left Atrial Appendage Ligation
Lead Sponsor:
Henry Ford Health System
Conditions:
Atrial Fibrillation
Left Atrial Appendage Ligation
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
We use a tiny catheter through the heart to separate the pericardium with gas. We expect this to improve the safety of the Lariat procedure.
Detailed Description
The Lariat suture device enables non-surgical exclusion of the left atrial appendage possibly to prevent thromboembolism and stroke in patients with atrial fibrillation. Subxiphoid needle access to th...
Eligibility Criteria
Inclusion
- Undergoing subxiphoid access to the "empty" pericardial space as part of a Lariat left atrial appendage exclusion procedure
- Age ≥ 21 years
Exclusion
- • Does not consent to participate
Key Trial Info
Start Date :
May 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT06584370
Start Date
May 1 2014
End Date
August 1 2015
Last Update
September 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Health System
Detroit, Michigan, United States, 48202